BIO-TECHNE Corp 4

Bio‑Techne Corp CFO James Hippel exercised 62,068 options at $47.60 and disposed of 51,024 shares for tax withholding at $72.03, ending with 164,714 directly owned common shares.

On July 29, 2026, Bio‑Techne Corp CFO James Hippel exercised 62,068 stock options at an exercise price of $47.60 per share (Code M), acquiring an equivalent number of common shares valued at approximately $2.95 million based on the exercise price, and on the same date had 51,024 shares withheld or sold to cover taxes or related obligations at a price of $72.03 per share (Code F), valued at roughly $3.67 million. Following these transactions, his direct ownership increased to 215,738 shares before the tax-related disposition and stood at 164,714 shares of common stock directly owned after the withholding transaction. The filing also lists a series of previously granted stock options, performance stock options, restricted stock units, and performance restricted stock units with various exercise prices, vesting schedules, and expiration/maturity dates extending out to 2035, which are routine elements of his long‑term equity compensation package and did not themselves represent new grants or disposals in this filing.

Filing Facts

CIK

842023

Ticker

TECH

Form

4

Source Type

fda

Accession

0000914190-26-000108

Alert Tier

6